The custom chip maker added a fourth customer that is expected to deliver $10 billion in revenue, and Mizuho analysts believe it could be OpenAI rival Anthropic.

Almost all health-insurance claim denials go uncontested, but an AI solution is like “TurboTax for appeals,” one company’s expert says.

Tesla will be riding one of its strongest delivery periods in history but will also have to face questions about its future in autonomy.

A J.P. Morgan analyst downgrades Goldman Sachs to neutral from overweight, saying Barclays and Deutsche Bank offer more potential upside.

Experts warn that stolen jewelry finds its way into the mainstream market all the time, so buyer beware.

Ozempic maker Novo Nordisk is shaking up its board.

A pioneer in AI pours cold water on hopes that the explosion of spending will lead to a productivity boost anytime soon.

“I’m in my late 40s and I am a civilian employee who is reporting for duty but not getting paid.”

Israel’s war with Hamas has taken its economy some 7% below the trend, but a big recovery is due if the war doesn’t resume, say economists at Goldman Sachs in a new analysis.

The Big Tech stocks known as the “Magnificent Seven” are expected to produce much stronger earnings growth than the rest of the S&P 500 over the next 12 months — but that gap may start shrinking in early 2026.

GE Aerospace shares rallied into record territory after a big earnings beat and a raised full-year outlook.

If China’s demand slows, gold’s price will decline. Much is riding on U.S.-China politics.

A panel discussion at the recent J.P. Morgan/Robinhood Investors Conference offered up ideas for some important AI investments investors should be looking at now.

BLS’s September inflation report will set Social Security’s 2026 cost-of-living adjustment.

GM doesn’t anticipate tariff costs to be as steep as it previously expected. The automaker is also benefiting from higher prices, and says its move to trim EV production will pay off next year.

Price increases offset flat sales in certain business units.

The short-term setup could be promising for AMD’s stock, according to Bernstein. But delivering over a longer period gets more complicated.

More important than a brief AWS outage is whether Amazon can reaccelerate cloud growth and use its earnings report later this month to shake off concerns that it’s an AI laggard.

Selling Rivian’s expensive electric trucks and SUVs may get more difficult now that key tax credits have expired.

It’s a prime time to pick stocks right now, says Morgan Stanley, they have some ideas.

The iPhone maker’s shares tend to rise in the last 3 months of the year, says Evercore

An executive at AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of company sales in five years’ time.

Investors are climbing a “wall of worry,” when it comes to all-important U.S. assets. That shouldn’t deter them, says Indosuez Wealth Management’s chief strategist.

“She passed away in December 2025. So far, no one in the family has received anything from her estate.”

As they prepare to meet in 10 days on interest rates, Federal Reserve officials are very divided over a key question: How worried they ought to be about the U.S. labor market.